Table 2 Therapeutic and prognosis characteristics
Treatment characteristics | |
Systemic anticoagulation,n(%) | 12 (80.0%) |
LMWH, n (%) | 11 (73.3%) |
Unfractionated heparin, n (%) | 1 (6.7%) |
Chemotherapy | 5 (33.3%) |
Interventional treatment | 4 (26.7%) |
Mechanical thrombectomy | 2 (13.3%) |
TIPS | 2 (13.3%) |
Outcomes | |
Mortality at 6 months | 7 (46.7%) |
Progression of underlying disease | 6 (40.0%) |
Progression of cancer | 4 (26.7%) |
Progression of liver abscess | 2 (13.3%) |
Unknown cause of death | 1 (6.7%) |
Progression to cirrhosis | 1 (6.7%) |